MIRO - Miromatrix Medical Inc.
Close
3.39
0.020 0.590%
Share volume: 0
Last Updated: Tue 12 Dec 2023 10:00:00 PM CET
Biological Product (except Diagnostic) Manufacturing :
-4.32%
PREVIOUS CLOSE
CHG
CHG%
$3.37
0.02
0.59%
View ratios
| Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | |
| Report Date | 2022-05-16 | 2022-08-15 | 2022-11-14 | 2023-03-31 | 2023-05-11 | 2023-08-14 | 2023-11-14 | |
| Assets | ||||||||
| Total Assets | 53.957 M | 47.654 M | 40.608 M | 34.763 M | 34.242 M | 28.451 M | 23.421 M | |
| Current Assets | 46.144 M | 33.959 M | 32.835 M | 27.311 M | 27.348 M | 21.881 M | 17.192 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 652.226 K | 481.582 K | 481.902 K | 382.813 K | 935.236 K | 672.793 K | 319.355 K | |
| Short Term Investments | 652.226 K | 481.582 K | 481.902 K | 382.813 K | 935.236 K | 672.793 K | 319.355 K | |
| Total Receivables | 6.768 K | 3.952 K | 12.395 K | 930.355 K | 7.981 K | 8.517 K | 11.176 K | |
| Current Cash | 44.685 M | 32.674 M | 31.541 M | 25.197 M | 25.605 M | 20.400 M | 16.062 M | |
| Total Non-current Assets | 7.813 M | 13.695 M | 7.772 M | 7.452 M | 6.894 M | 6.570 M | 6.229 M | |
| Property Plant Equipment | 5.992 M | 5.792 M | 5.816 M | 5.546 M | 5.271 M | 4.999 M | 4.711 M | |
| Other Assets | 1.821 M | 1.964 M | 1.956 M | 1.906 M | 1.623 M | 1.571 M | 1.518 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||||
| Total Liabilities and shareholders’ equity | 53.957 M | 47.654 M | 40.608 M | 34.763 M | 34.242 M | 28.451 M | 23.421 M | |
| Total liabilities | 6.500 M | 7.643 M | 7.865 M | 8.656 M | 6.442 M | 6.903 M | 7.879 M | |
| Total current liabilities | 2.489 M | 3.736 M | 4.058 M | 4.946 M | 3.325 M | 3.887 M | 4.966 M | |
| Accounts Payable | 478.866 K | 1.079 M | 1.158 M | 1.585 M | 1.172 M | 803.571 K | 1.048 M | |
| Other liabilities | 569.995 K | 576.949 K | 583.827 K | 590.781 K | 106.118 K | 113.409 K | 120.780 K | |
| Current long term debt | 402.586 K | 470.527 K | 450.253 K | 433.806 K | 430.979 K | 428.072 K | 430.931 K | |
| Long term debt | 3.441 M | 3.330 M | 3.223 M | 3.118 M | 3.011 M | 2.902 M | 2.792 M | |
| Other liabilities | 569.995 K | 576.949 K | 583.827 K | 590.781 K | 106.118 K | 113.409 K | 120.780 K | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 47.457 M | 40.011 M | 32.743 M | 26.107 M | 27.800 M | 21.548 M | 15.542 M | |
| Common stock | 20.478 M | 20.615 M | 20.896 M | 20.923 M | 22.508 M | 27.251 M | 27.314 M | |
| Retained earnings | -81.256 M | -89.438 M | -97.066 M | -104.012 M | -111.492 M | -118.022 M | -124.476 M |